Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Xin-yan ZHU"'
Publikováno v:
Journal of Integrative Agriculture, Vol 17, Iss 3, Pp 640-647 (2018)
High-performance liquid chromatography (HPLC) was employed to determine drug release rates based on emamectin benzoate concentrations in the medium. Release kinetics equations were used to fit the drug release behavior. The effects of particle size a
Externí odkaz:
https://doaj.org/article/fbde25aeebbb48049fa24f99ebd154f1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wei-Fen Xie, Xin Zhang, Cheng Luo, Bing Zhou, Ya-Xi Yang, Feng Yang, Shu-Qing Liu, Xin-Yan Zhu, Bai-Nan Zheng, Chen-Hong Ding, Qin-Juan Sun, Sen-Hao Xiao, Shi-Jie Chen, Ling-Yan Cai
Targeting epigenetics in cancer has emerged as a promising anticancer strategy. p300/CBP is a central regulator of epigenetics and plays an important role in hepatocellular carcinoma (HCC) progression. Tumor-associated metabolic alterations contribut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4089fc03e9da46a37584289439bffab1
https://doi.org/10.1158/0008-5472.c.6512751.v1
https://doi.org/10.1158/0008-5472.c.6512751.v1
Autor:
Wei-Fen Xie, Xin Zhang, Cheng Luo, Bing Zhou, Ya-Xi Yang, Feng Yang, Shu-Qing Liu, Xin-Yan Zhu, Bai-Nan Zheng, Chen-Hong Ding, Qin-Juan Sun, Sen-Hao Xiao, Shi-Jie Chen, Ling-Yan Cai
Supplementary Table S3. Pathway analysis of differentially expressed genes in RNA-seq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d2942782b2ec3faa87be871dfba2d42
https://doi.org/10.1158/0008-5472.22427601.v1
https://doi.org/10.1158/0008-5472.22427601.v1
Autor:
Wei-Fen Xie, Xin Zhang, Cheng Luo, Bing Zhou, Ya-Xi Yang, Feng Yang, Shu-Qing Liu, Xin-Yan Zhu, Bai-Nan Zheng, Chen-Hong Ding, Qin-Juan Sun, Sen-Hao Xiao, Shi-Jie Chen, Ling-Yan Cai
Supplementary Figure S1. p300 is a potential target in HCC. Supplementary Figure S2. B029-2 is a potential and selective catalytic p300/CBP inhibitor that targets HCC.Supplementary Figure S3. Targeting p300 suppresses the cell-proliferation of HCC ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30e653b27489bf00bf65120ce4f202b9
https://doi.org/10.1158/0008-5472.22427613.v1
https://doi.org/10.1158/0008-5472.22427613.v1
Autor:
Feng Yang, Bai-Nan Zheng, Qin-Juan Sun, Wei-Fen Xie, Bing Zhou, Chen-Hong Ding, Cheng Luo, Ling-Yan Cai, Senhao Xiao, Xin Zhang, Yaxi Yang, Shijie Chen, Shu-Qing Liu, Xin-Yan Zhu
Publikováno v:
Cancer research. 81(4)
Targeting epigenetics in cancer has emerged as a promising anticancer strategy. p300/CBP is a central regulator of epigenetics and plays an important role in hepatocellular carcinoma (HCC) progression. Tumor-associated metabolic alterations contribut
Autor:
Xin Yan Zhu, Fei Liu
Publikováno v:
Journal of Digestive Diseases. 18:195-202
Over 80% of individuals infected with Helicobacter pylori (H. pylori) are asymptomatic. Increased resistance to antibiotics and decreased compliance to the therapeutic regimens have led to the failure of eradication therapy. Probiotics, with direct a
Publikováno v:
Injury. 51:1406-1407
Publikováno v:
International Journal of Surgery. 76:7-8
Publikováno v:
The American Journal of the Medical Sciences. 358:59-60